Zarei Edalat, Shafiekhani Mojtaba, Azadeh Nazanin, Shamsaeefar Alireza, Lotfi Mahnaz, Ahrami Mahbube, Rabbani Amirhassan, Nikoupour Hamed
Shiraz Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Asian J Transfus Sci. 2022 Jan-Jun;16(1):135-139. doi: 10.4103/ajts.ajts_18_21. Epub 2022 May 26.
Passenger lymphocyte syndrome (PLS) is a well-described phenomenon causing immune hemolytic anemia, mostly in non-ABO identical transplantations. The syndrome occurs when donor lymphocytes produce antibodies against the recipient's red blood cells. Although the syndrome is usually self-limited, further management with blood transfusions, immunosuppression, or plasmapheresis might be needed. A 23-year-old female with AB blood group underwent small intestine transplantation from a deceased donor with O blood group. She received rituximab, thymoglobin, and methylprednisolone as immunosuppressive induction. In the 9 postoperation day, she developed hemolysis which was primarily managed with blood transfusions and finally ceased by plasmapheresis and intravenous immunoglobulin. Few cases of PLS have been previously described in intestinal transplantation recipients. Correct diagnosis and management prevents severe hemolysis outcomes. Previous cases have been successfully treated with a combination of immune suppression, plasma exchange, and transfusions.
过客淋巴细胞综合征(PLS)是一种已被充分描述的现象,主要在非ABO血型相同的移植中导致免疫性溶血性贫血。当供体淋巴细胞产生针对受者红细胞的抗体时,就会出现该综合征。尽管该综合征通常为自限性,但可能需要通过输血、免疫抑制或血浆置换进行进一步治疗。一名23岁AB血型的女性接受了来自一名已故O血型供体的小肠移植。她接受了利妥昔单抗、抗胸腺细胞球蛋白和甲泼尼龙作为免疫抑制诱导治疗。术后第9天,她出现了溶血,主要通过输血进行治疗,最终通过血浆置换和静脉注射免疫球蛋白得以缓解。此前在小肠移植受者中很少有PLS病例的报道。正确的诊断和治疗可预防严重的溶血后果。先前的病例通过免疫抑制、血浆置换和输血联合治疗已成功治愈。